News & Events

/bezlotoxumab-real-world-study-demonstrates-success-in-prevention-of-clostridioides-difficile-infection
Healix Infusion Therapy and Collaborators Publish Real-World Experience of Bezlotoxumab for Prevention of <em>Clostridioides difficile</em> Infection: A Retrospective Multicenter Cohort Study

Healix Infusion Therapy and Collaborators Publish Real-World Experience of Bezlotoxumab for Prevention of Clostridioides difficile Infection: A Retrospective Multicenter Cohort Study

SUGAR LAND, TX – (March 20, 2020) Healix Infusion Therapy, LLC, announced today the publication of a collaborative study in the leading scientific journal, Open Forum Infectious Diseases. This real-world multicenter study demonstrated successful prevention of...

Read More

Thank you healthcare heroes!
Thank You Healthcare Heroes!

Thank You Healthcare Heroes!

The team at Healix would like to thank all the healthcare heroes who are on the front lines treating patients during this unprecedented time with the COVID-19 crisis. We know you are faced with new challenges every day, and we are sincerely grateful, now more than...

Read More

Jackson Square in New Orleans, Louisiana at dusk, featuring St. Louis Cathedral illuminated against a pink and purple sky, with horse-drawn carriages lined up in the foreground.
CHEST Annual Meeting

CHEST Annual Meeting

New Orleans, LA Our team is excited to attend the 2019 CHEST Annual Meeting in New Orleans, LA, October 21-23, 2019. Our team would love to meet with you to discuss how Healix can help you establish an office infusion center or outsource the management of an...

Read More

The U.S. Capitol Building illuminated at night, reflected in the Capitol Reflecting Pool against a deep blue sky in Washington, D.C.
IDWeek

IDWeek

Washington, D.C. Healix is a proud Bronze Sponsor of IDWeek 2019! Uniquely focused in infectious disease (ID) and supporting over 300 Infectious Disease physicians across the country we are the nation's leader in providing physician office-based infusion services....

Read More